Volume 20, Number 11—November 2014
Research
Sequelae of Foodborne Illness Caused by 5 Pathogens, Australia, Circa 2010
Laura Ford, Martyn Kirk
, Kathryn Glass, and Gillian Hall
, Kathryn Glass, and Gillian Hall
Table 3
Estimated number of sequelae illnesses resulting from domestically acquired foodborne bacterial gastroenteritis, Australia, circa 2010*
| Sequelae, pathogen | Median no. Illnesses (90% CrI) | Median rate (90% CrI)† |
|---|---|---|
| GBS, Campylobacter spp. |
70 (30–150) |
3.1 (2–6) |
| HUS, STEC |
70 (25–200) |
3.3 (1–9) |
| IBS | ||
| Campylobacter spp | 15,600 (9,000–26,500) | 915 (570–1,440) |
| Nontyphoidal Salmonella spp.‡ | 3,500 (1,900–6,500) | |
| Shigella spp. | 30 (10–80) | |
| Total§ |
19,500 (12,500–30,700) |
|
| ReA | ||
| Campylobacter spp. | 12,500 (5,500–25,500) | 765 (415–1,375) |
| Nontyphoidal Salmonella spp.‡ | 3,250 (700–9,000) | |
| Shigella spp. | 29 (10–75) | |
| Yersinia enterocolitica | 150 (50–300) | |
| Total§ |
16,200 (8,500–30,000) |
|
| Total | 35,840 (25,000–54,000) | 1,620 (1,150–2,450) |
*CrI, credible interval; GBS, Guillain-Barré syndrome; HUS, hemolytic uremic syndrome; IBS, irritable bowel syndrome; ReA, reactive arthritis; STEC, Shiga toxin–producing Escherichia coli.
†No. cases per million population.
‡i.e., nontyphoidal S. enterica serotypes.
§Simulated values, which might not add to total because of rounding and variation over simulations.
Page created: October 15, 2014
Page updated: October 15, 2014
Page reviewed: October 15, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.